Dr. Bonifacio brings more than 7 years of experience in drug development to Aravive Biologics. She spent 4 years at Furiex Pharmaceuticals, Inc and was responsible for managing an 11-study clinical pharmacology program and preparing the Clinical Pharmacology Summary for a late stage GI program that is now on the market in the US and EU. She also helped manage clinical development programs in the metabolic and antibiotic arenas and led the efforts to strategize the nonclinical development and white paper production for an antibiotic that was of interest to BARDA. After Furiex was purchased by Allergan, Dr. Bonifacio started her own business to help small biotechnology companies successfully navigate the preIND process and she has successfully managed two such programs. She is a member of the Board of Directors for a small biotechnology company. Her expertise is in transitioning preIND programs successfully into and through clinical development and she has expertise in oncology, GI, antibiotics, metabolic, and urogenital. Dr. Bonifacio received her PharmD and PhD in Pharmaceutical Sciences from the Eshelman School of Pharmacy, University of North Carolina at Chapel Hill.
Laura Bonifacio, PharmD, PhD
Vice President, Clinical Programs